Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Patients with Frailty, Medical Comorbidities or Prior Lower Urinary Tract Surgery

Author： Liao Chun-Hou Wang Chung-Cheng Jiang Yuan-Hong

Publisher： MDPI

E-ISSN： 2072-6651|8|4|91-91

ISSN： 2072-6651

Source： Toxins, Vol.8, Iss.4, 2016-03, pp. : 91-91

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?

By Kuo Yuh-Chen Kuo Hann-Chorng

Toxins, Vol. 8, Iss. 3, 2016-03 ,pp. : 75-75

MDPI

Access to resources Recommend Favorite

Efficacy and Safety of Intravesical OnabotulinumtoxinA Injection in Patients with Detrusor Hyperactivity and Impaired Contractility

By Wang Chung-Cheng Lee Cheng-Ling Kuo Hann-Chorng

Toxins, Vol. 8, Iss. 3, 2016-03 ,pp. : 82-82

MDPI

Access to resources Recommend Favorite

Onabotulinumtoxin A for Treating Overactive/Poor Compliant Bladders in Children and Adolescents with Neurogenic Bladder Secondary to Myelomeningocele

By Marte Antonio

Toxins, Vol. 5, Iss. 1, 2012-12 ,pp. : 16-24

MDPI

Access to resources Recommend Favorite

Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature

By Moore David C. Cohn Joshua A. Dmochowski Roger R.

Toxins, Vol. 8, Iss. 4, 2016-03 ,pp. : 88-88

MDPI

Access to resources Recommend Favorite

Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action

By Jhang Jia-Fong Kuo Hann-Chorng

Toxins, Vol. 8, Iss. 4, 2016-04 ,pp. : 120-120

MDPI

Access to resources Recommend Favorite